Skip to content

Prospective registration of patients with duodenal adenomas: endoscopic therapy, complications and duration of remission

Prospective registration of patients with duodenal adenomas: endoscopic therapy, complications and duration of remission

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00003081
Enrollment
100
Registered
2011-05-11
Start date
2011-05-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D13.2 D12.6

Interventions

Group 1: endoscopic resection of the duodenal adenoma with subsequent registration of complications and duration of remission

Sponsors

HSK Wiesbaden
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - age over 18 years -patients with suspected or diagnosed duodenal adenomas

Exclusion criteria

Exclusion criteria: - missing consent - pregnacy - Coagulation disorders (Quick 50 s, WBC< 100.000/ml)

Design outcomes

Primary

MeasureTime frame
The goal of the study is the systematic registration of patients with duodenal adnnomas at the Dr. Horst Schmidt Klinik in Wiesbaden. Primary outcome is to clarify the complication rate for endoscopic therapy of duodenal adenomas and to see which complications occure in which frequency

Secondary

MeasureTime frame
Secondary outcomes of the study are: - influence of the complication rate concerning size, location, histology, pattern), type of endocopic therapy (resection en bloc-piece meal-APC-therapy ) - duration till complete remission and duration of remission

Countries

Germany

Contacts

Public ContactInsa Messer

HSK Wiesbaden

Insa.Messer@hsk-wiesbaden.de0611432194

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026